| 0.7398 -0.05 (-6.35%) | 08-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.96 |
1-year : | 1.06 |
| Resists | First : | 0.82 |
Second : | 0.91 |
| Pivot price | 0.76 |
|||
| Supports | First : | 0.68 | Second : | 0.57 |
| MAs | MA(5) : | 0.79 |
MA(20) : | 0.77 |
| MA(100) : | 0.9 |
MA(250) : | 1.16 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 49.6 |
D(3) : | 64.9 |
| RSI | RSI(14): 40.8 |
|||
| 52-week | High : | 3.09 | Low : | 0.68 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ QSI ] has closed above bottom band by 32.9%. Bollinger Bands are 48% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.77 - 0.77 | 0.77 - 0.78 |
| Low: | 0.7 - 0.71 | 0.71 - 0.71 |
| Close: | 0.73 - 0.74 | 0.74 - 0.75 |
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Thu, 13 Aug 2026
Quantum-Si Q2 Earnings Call Highlights - TradingView
Thu, 13 Aug 2026
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Thu, 13 Aug 2026
Quantum-Si (NASDAQ:QSI) Announces Quarterly Earnings Results - MarketBeat
Thu, 13 Aug 2026
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus Development Update - Investing News Network
Thu, 13 Aug 2026
Quantum-Si incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Thu, 13 Aug 2026
Stock Traders Purchase Large Volume of Call Options on Quantum-Si (NASDAQ:QSI) - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 198 (M) |
| Held by Insiders | 1.7919e+008 (%) |
| Held by Institutions | 10.5 (%) |
| Shares Short | 22,510 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -9.123e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -9 % |
| Return on Assets (ttm) | 322.8 % |
| Return on Equity (ttm) | -24.8 % |
| Qtrly Rev. Growth | 1.85e+006 % |
| Gross Profit (p.s.) | -21.36 |
| Sales Per Share | -14.28 |
| EBITDA (p.s.) | 228000 |
| Qtrly Earnings Growth | -0.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -94 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.06 |
| Price to Cash Flow | 2.61 |
| Dividend | 0 |
| Forward Dividend | 1.413e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|